MM-120 Archives | High Times

New York
News
Psychedelics

Biotech Firm Launches Trial To Study LSD As Treatment For Anxiety

New York-based biopharmaceutical developer MindMed announced last week that it has dosed the first patient in a clinical trial of LSD as a treatment for generalized anxiety disorder.

byA.J. Herrington

August 29, 2022

The Latest

Psychedelic Conversations at Madame ZuZu’s Emporium

The Fake Era: Sprayed Terps

GPS Fail Sends Driver With Almost 400 Pounds of Pot to U.S.-Canada Border

MM-120

Biotech Firm Launches Trial To Study LSD As Treatment For Anxiety

Psychedelic Conversations at Madame ZuZu’s Emporium

The Fake Era: Sprayed Terps

GPS Fail Sends Driver With Almost 400 Pounds of Pot to U.S.-Canada Border

Minnesota Breweries See Benefits From State’s Cannabis Law